Stockreport

Incyte Remains Undervalued As Opzelura And Niktimvo Scale [Seeking Alpha]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF In my view, the key drivers of raised investor interest in Incyte are the strong performance of its ruxolitinib franchise. By the way, Incyte expects Opzelura sales t [Read more]